FASEB J. Innocentive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kam, M.
Right arrow Articles by Addadi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kam, M.
Right arrow Articles by Addadi, L.

The FASEB Journal, Vol 6, 2608-2613, Copyright © 1992 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Antibodies against crystals

M Kam, D Perl-Treves, D Caspi and L Addadi
Dept of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.

We suggest that crystals, when introduced into an organism, may behave as conventional antigens, mediating the production of specific antibodies. These antibodies would bear an imprint of the crystal surface and may consequently behave as a nucleating matrix in a new crystallization event. Thus, they would behave as catalytic antibodies. We show that IgG antibodies isolated from patients suffering from gout, a joint disease caused by crystals of monosodium urate monohydrate (MSUM), accelerate the appearance of new crystals of MSUM from a supersaturated solution of the salt in vitro. The same effect is not observed for IgG antibodies isolated from the joint fluids of patients with other joint diseases, such as pseudogout, rheumatoid arthritis, or osteoarthritis. Furthermore, IgG antibodies obtained from rabbits injected subcutaneously with crystals of MSUM, were also nucleating towards MSUM crystals.


This article has been cited by other articles:


Home page
J. Immunol.Home page
U. Kanevets, K. Sharma, K. Dresser, and Y. Shi
A Role of IgM Antibodies in Monosodium Urate Crystal Formation and Associated Adjuvanticity
J. Immunol., February 15, 2009; 182(4): 1912 - 1918.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Dalbeth and D. O. Haskard
Mechanisms of inflammation in gout
Rheumatology, September 1, 2005; 44(9): 1090 - 1096.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Schreiner, E. Wandel, F. Himmelsbach, P. R. Galle, and E. Marker-Hermann
Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
Nephrol. Dial. Transplant., May 1, 2000; 15(5): 644 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D Hanein, H Sabanay, L Addadi, and B Geiger
Selective interactions of cells with crystal surfaces. Implications for the mechanism of cell adhesion
J. Cell Sci., January 2, 1993; 104(2): 275 - 288.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.